This session was conducted as a part of the 6th Resident Professional Development Course titled "Evidence-Based Medicine" in 9th SEPT 2015 at College of Medicine, King Saud University
Overview of Evidence-Based Practice Guidelines Initiatives in the Hospitals of Two Universities in the Middle East and North Africa Countries: Alexandria University Faculty of Medicine and University Hospitals and King Saud University College of Medicine and Medical City
An introduction on Evidence-Based Clinical Practice Guidelines in Health Care Organizations
Brief on Alexandria Center for EBCPGs in Alexandria University Hospitals, Egypt
By Dr. Yasser Sami Abdel Dayem Amer, MBBCh, MS 2013
Special Thanks to
Prof Dr Mahmoud Elzalabany
Prof Dr Tarek Omar
Prof Dr Nabil Dowidar
Prof Dr Afaf Gaber
Part 1. An overview on implementation of CPGs
Part 2. CPGs & HTAs
Presented during the 2nd Regional Workshop for CPG Adaptation, Tunis, Tunisia May 24-26 2016
A collaborative between INA Sante, WHO-EMRO, KSU
An Overview on Evidence-Based Clinical Guidelines for the Staff of the NICU of King Saud Medical City Presented in Wednesday March 20th, 2013 in Riyadh, KSA by Dr. Yasser Sami Amer
Participants: Dr Nabil AlOthaidan, Dr Haider Sumaily, Dr Tarek Abo ElMaaty, Dr Mohamed Jaaffar, Dr Samer Askoul, Dr Kussai Awad, Dr Angelito Narito, Dr Faiza Gaber, Dr Eiman Darwish, Dr Sharifa Alassiri. Michael Randy, Shanon and Dr Yazid, Dr Omnia, Dr Alaa and Dr Titiana and the respectable staff of the NICU in KSMC.
Special Thanks to Miss Nawf El-Noumsy for organization
What is the difference between development and adaptation of clinical practice guidelines? This was presented by Dr. Yasser Amer during the 2nd Regional Workshop for CPG adaptation, Tunis, Tunisia May 24-26 2016
Link:
https://www.facebook.com/media/set/?set=a.481589005298936.1073741852.215244758600030&type=1&l=67dff997c7
The Adapted ADAPTE approach to CPG adaptation proposed by the Alexandria Center for Evidence-Based Clinical Practice Guidelines, Alexandria University, Egypt.
An oral presentation conducted by Prof. Tarek Omar during the national initiative of the Pediatrics Department, Armed Forces College of Medicine, themed; 'Towards National Guidelines' that was launched in 2018 and started by Pediatrics CPGs
Overview of Evidence-Based Practice Guidelines Initiatives in the Hospitals of Two Universities in the Middle East and North Africa Countries: Alexandria University Faculty of Medicine and University Hospitals and King Saud University College of Medicine and Medical City
An introduction on Evidence-Based Clinical Practice Guidelines in Health Care Organizations
Brief on Alexandria Center for EBCPGs in Alexandria University Hospitals, Egypt
By Dr. Yasser Sami Abdel Dayem Amer, MBBCh, MS 2013
Special Thanks to
Prof Dr Mahmoud Elzalabany
Prof Dr Tarek Omar
Prof Dr Nabil Dowidar
Prof Dr Afaf Gaber
Part 1. An overview on implementation of CPGs
Part 2. CPGs & HTAs
Presented during the 2nd Regional Workshop for CPG Adaptation, Tunis, Tunisia May 24-26 2016
A collaborative between INA Sante, WHO-EMRO, KSU
An Overview on Evidence-Based Clinical Guidelines for the Staff of the NICU of King Saud Medical City Presented in Wednesday March 20th, 2013 in Riyadh, KSA by Dr. Yasser Sami Amer
Participants: Dr Nabil AlOthaidan, Dr Haider Sumaily, Dr Tarek Abo ElMaaty, Dr Mohamed Jaaffar, Dr Samer Askoul, Dr Kussai Awad, Dr Angelito Narito, Dr Faiza Gaber, Dr Eiman Darwish, Dr Sharifa Alassiri. Michael Randy, Shanon and Dr Yazid, Dr Omnia, Dr Alaa and Dr Titiana and the respectable staff of the NICU in KSMC.
Special Thanks to Miss Nawf El-Noumsy for organization
What is the difference between development and adaptation of clinical practice guidelines? This was presented by Dr. Yasser Amer during the 2nd Regional Workshop for CPG adaptation, Tunis, Tunisia May 24-26 2016
Link:
https://www.facebook.com/media/set/?set=a.481589005298936.1073741852.215244758600030&type=1&l=67dff997c7
The Adapted ADAPTE approach to CPG adaptation proposed by the Alexandria Center for Evidence-Based Clinical Practice Guidelines, Alexandria University, Egypt.
An oral presentation conducted by Prof. Tarek Omar during the national initiative of the Pediatrics Department, Armed Forces College of Medicine, themed; 'Towards National Guidelines' that was launched in 2018 and started by Pediatrics CPGs
Clinical Practice Guidelines initiative by the Healthcare Quality Directorate of the Alexandria University Hospitals, Alexandria, Egypt. For further details please refer to http://onlinelibrary.wiley.com/doi/10.1111/jep.12479/full
A personalized training workshop for the PRM Department Staff at KSUMC at large. The specific target audience is the CPG working groups and new committee members.
Alexandria Pediatric Center - Scientific Meeting Series 2017 - Meeting No. (7) conducted by Dr. Yasser Sami Amer
on 22nd August 2017 in Alexandria, Egypt
Overview of the progress of the KSUMC Clinical Practice Guidelines Adaptation and Implementation Program in the Department of Pediatrics which is the most active department in the program
EVIDENCE-BASED CPGs FOR HEMATOLOGY - ONCOLOGY UNIT, KING SAUD UNIVERSITY HOPSITALS
Saudi Arabia, Riyadh
King Saud University Hospitals
CPGs Committee
Quality Management Dept
CPGs Program
By YASSER SAMI AMER
A Presentation that promotes Evidence-Based Psychiatry and informed clinical decision making in the daily practice of Psychiatry. Prepared by Dr Yasser Amer and Dr Maged Elesely
A parallel workshop to the first international Evidence-based medicine conference and workshop Adopting Clinical Guidelines where I participated as a guest speaker.
https://www.ssrsa.org/
The final protocol (v5.3). Notable changes include:
1) Confirmation of audit standard (Page 6).
2) Refinement of inclusion and exclusion criteria (Page 7)
3) Confirmation of audit status (Appendix C)
4) Refinement of required data fields (Page 19) including definitions (Pages 20-25)
An awareness session conducted for physicians of the psyhciatry department at KSUMC on Monday 25/11/2019 at King Khalid University Hospital, Riyadh, KSA
How Researchers Can Get Science Done Faster Using an R&D Services MarketplaceSC CTSI at USC and CHLA
Date: Feb 6, 2019
Topic: How Researchers Can Get Science Done Faster Using an R&D Services Marketplace
Speaker: Dr. Zev Wisotsky is a Senior Scientist and R&D Specialist at Science Exchange, where he assists researchers in connecting with the right R&D providers for their experiments and alerts his clients to newly available technologies. Dr. Wisotsky earned his PhD in neuroscience investigating taste detection using fruit fly and mosquito models at UC Riverside. He then completed postdoctoral research at Stanford studying the role of brain regions involved in fear memory and addiction through optogenetic silencing of different brain circuits.
Overview: Science Exchange is an open marketplace for scientific research that breaks down barriers to collaboration and innovation. The platform makes it easy for researchers to access more than 6,000 services from a network of over 2,500 qualified research providers. In this webinar, you will learn how researchers can use Science Exchange to access new technologies, get competitive quotes for specific projects, and order from any service provider under a single, pre-established contract. The presentation will also include examples of successful projects and collaborations, initiated on the Science Exchange platform, that have accelerated breakthrough
Pathophysiology of thromboembolism during pregnancywendwesen alemu
Basic info's about virchows traid,risk factors for TE during pregnancy,hypercoagulabiltiy states,APAS,factor V Leiden, protein C,and Antithrombin iii deficiency
Clinical Practice Guidelines initiative by the Healthcare Quality Directorate of the Alexandria University Hospitals, Alexandria, Egypt. For further details please refer to http://onlinelibrary.wiley.com/doi/10.1111/jep.12479/full
A personalized training workshop for the PRM Department Staff at KSUMC at large. The specific target audience is the CPG working groups and new committee members.
Alexandria Pediatric Center - Scientific Meeting Series 2017 - Meeting No. (7) conducted by Dr. Yasser Sami Amer
on 22nd August 2017 in Alexandria, Egypt
Overview of the progress of the KSUMC Clinical Practice Guidelines Adaptation and Implementation Program in the Department of Pediatrics which is the most active department in the program
EVIDENCE-BASED CPGs FOR HEMATOLOGY - ONCOLOGY UNIT, KING SAUD UNIVERSITY HOPSITALS
Saudi Arabia, Riyadh
King Saud University Hospitals
CPGs Committee
Quality Management Dept
CPGs Program
By YASSER SAMI AMER
A Presentation that promotes Evidence-Based Psychiatry and informed clinical decision making in the daily practice of Psychiatry. Prepared by Dr Yasser Amer and Dr Maged Elesely
A parallel workshop to the first international Evidence-based medicine conference and workshop Adopting Clinical Guidelines where I participated as a guest speaker.
https://www.ssrsa.org/
The final protocol (v5.3). Notable changes include:
1) Confirmation of audit standard (Page 6).
2) Refinement of inclusion and exclusion criteria (Page 7)
3) Confirmation of audit status (Appendix C)
4) Refinement of required data fields (Page 19) including definitions (Pages 20-25)
An awareness session conducted for physicians of the psyhciatry department at KSUMC on Monday 25/11/2019 at King Khalid University Hospital, Riyadh, KSA
How Researchers Can Get Science Done Faster Using an R&D Services MarketplaceSC CTSI at USC and CHLA
Date: Feb 6, 2019
Topic: How Researchers Can Get Science Done Faster Using an R&D Services Marketplace
Speaker: Dr. Zev Wisotsky is a Senior Scientist and R&D Specialist at Science Exchange, where he assists researchers in connecting with the right R&D providers for their experiments and alerts his clients to newly available technologies. Dr. Wisotsky earned his PhD in neuroscience investigating taste detection using fruit fly and mosquito models at UC Riverside. He then completed postdoctoral research at Stanford studying the role of brain regions involved in fear memory and addiction through optogenetic silencing of different brain circuits.
Overview: Science Exchange is an open marketplace for scientific research that breaks down barriers to collaboration and innovation. The platform makes it easy for researchers to access more than 6,000 services from a network of over 2,500 qualified research providers. In this webinar, you will learn how researchers can use Science Exchange to access new technologies, get competitive quotes for specific projects, and order from any service provider under a single, pre-established contract. The presentation will also include examples of successful projects and collaborations, initiated on the Science Exchange platform, that have accelerated breakthrough
Pathophysiology of thromboembolism during pregnancywendwesen alemu
Basic info's about virchows traid,risk factors for TE during pregnancy,hypercoagulabiltiy states,APAS,factor V Leiden, protein C,and Antithrombin iii deficiency
Rising Importance of Health Economics & Outcomes ResearchCitiusTech
Health Economics & Outcomes Research (HE&OR) guides stakeholders to make informed decisions regarding patient access to drugs and services. This document highlights specific use cases for healthcare information technology that add value to HE&OR.
Point of Care Testing for Enhancing Patient Centered Planned Care DeliveryPAFP
PAFP 2013 Regional Lecture Series
Session 1 - Northeast
Presenter: Linda Thomas-Hemak, MD
The Wright Center for Primary Care
Broadcast live through the PAFP Community.
October 2nd, 2013 12pm - 1pm
Reducing stillbirth and early neonatal death, pop up uni, 11am, 3 september 2015NHS England
Expo is the most significant annual health and social care event in the calendar, uniting more NHS and care leaders, commissioners, clinicians, voluntary sector partners, innovators and media than any other health and care event.
Expo 15 returned to Manchester and was hosted once again by NHS England. Around 5000 people a day from health and care, the voluntary sector, local government, and industry joined together at Manchester Central Convention Centre for two packed days of speakers, workshops, exhibitions and professional development.
This year, Expo was more relevant and engaging than ever before, happening within the first 100 days of the new Government, and almost 12 months after the publication of the NHS Five Year Forward View. It was also a great opportunity to check on and learn from the progress of Greater Manchester as the area prepares to take over a £6 billion devolved health and social care budget, pledging to integrate hospital, community, primary and social care and vastly improve health and well-being.
More information is available online: www.expo.nhs.uk
Presented as part of the Capacity Building in Policy Briefs Development Workshop conducted by Research Chair for Evidence-Based Health Care and Knowledge Translation
In collaboration with World Health Organization, Regional Office for the Eastern Mediterranean in King Saud University 2019.
CPG adaptation project for Childhood CSE.
(Dissemination and Implementation Phase)
Training session for Pediatrics resident at King Khalid University Hospital, King Saud University Medical City
Illustration on how the CPGs Adaptation Program has helped in quality improvement through compliance with national and international accreditation standards.
ADAPTE Phase Two: ADAPTATION PHASE
Search and Screen Module
Presented by Dr. Yasser S. Amer during the 2nd Regional Workshop for CPG Adaptation in Tunis, Tunisia May 24-26, 2016
A collaborative between INA Sante, WHO-EMRO, King Saud University
A 15-minutes oral presentation that was given in ISQua's 32nd International Conference, Doha, October 2015 by Dr. Yasser Amer under the track: "Quality and Safety in Developing Countries"
The Appraisal of Guidelines for Research and Evaluation (AGREE) Instrument evaluates the process of practice guideline development and the quality of reporting.
The original AGREE Instrument has been updated and methodologically refined. The AGREE II is now the new international tool for the assessment of practice guidelines. The AGREE II is both valid and reliable and comprises 23 items organized into the original 6 quality domains.
http://www.agreetrust.org/
An overview on priorities in health research was a part of a course for research methodology delivered in King Saud University College of Medicine August 2015
CPG Implementation is “the phase in the guideline lifecycle in which strategies, systems, and tools are created to operationalize the knowledge and recommendations set forth by the guideline developers”, or is “ the part of the guideline lifecycle in which systems are introduced to influence clinicians’ behavior toward guideline adherence”. Implementation barriers and facilitators are defined as factors that actually prevent or enhance, respectively, changes in clinical behavior.
The concept of CPG Implementability was first defined by Shiffman as a set of characteristics that can predict the ease of and/ or obstacles to CPG implementation. Implementability is an abstract concept related to several factors, including intrinsic factors that are specific to the CPG itself and under control of the CPG development group) and extrinsic factors that are often specific to the intended healthcare settings and context of implementation. Also a validated tool for appraisal of implementability of CPGs named “GuideLine Implementability Appraisal (GLIA)” was developed by Schiffman RN et al, from the Yale Center for Medical Informatics, Yale School of Medicine and School of Nursing at Yale University in USA in 2005. A second version was released including a free online platform (electronic or e-GLIA). The GLIA considers only the intrinsic factors in the appraisal and is organized into two parts; part 1, including the global dimension with seven questions that examine the entire CPG document as a whole, and part 2, including the other nine dimensions with twenty-four questions that appraise each recommendation individually regarding the identified nine intrinsic factors or dimensions of implementability. The nine dimensions are decidability, executability, effect on the process of care, presentation and formatting, measurable outcomes, apparent validity, novelty/ innovation, flexibility, and computability.
An introductory overview of the basic concepts of Healthcare Quality, a starter for beginners.
Prepared in 2014 for the new staff of the Quality Management Department in King Saud University Medical City in Riyadh as a part of their capacity building plan.
Acknowledgments:
*Dr. Magdy Gamal Yousef, MBBCh, MS, CPHQ - for his contribution in the scientific content
**Ms. Maram Baksh, MS, CPHQ - for the design of the full HCQ capacity building plan in KSUMC
APPRAISAL OF GUIDELINES FOR RESEARCH & EVALUATION (AGREE) II Instrument: Assessment of the Quality of Clinical Practice Guidelines.
A training workshop presented to the healthcare professionals (i.e. physicians, nurses, pharmacists, technicians,...etc.) of King Khalid University Hospital, King Saud University in Riyadh, Saudi Arabia in August 2014.
I present my highest gratitude to all of my professors and colleagues who have and still inspire me.
Namely, Prof. Mahmoud El-Zalabany, Prof. Tarek Omar, Prof. Nabil Dowidar and Prof. Afaf Ibrahim (Alexandria Univ., EG), Prof. Abdelhamid Attia (Cairo Univ., EG), Prof. Lubna Al-Ansary, Dr. Hayfaa Wahbi, Dr. Rasmieh Alzeidan (King Saud Univ., KSA), Prof. David Sackett and Dr. Melissa Brouwers (McMaster Univ., CAN)
Adaptation and Implementation of Evidence-Based Clinical Practice Guidelines for Antibiotic Prophylaxis in Surgery in King Saud University Hospitals in Riyadh, Saudi Arabia
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Best Ayurvedic medicine for Gas and IndigestionSwastikAyurveda
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Towards Evidence-Based Clinical Practice Guidelines Implementation for Physicians at KSUMC
1. Towards EBCPGs
Implementation
for Physicians
Dr. Yasser S. Amer
MBBCh, MPed, MHCI, CPHQ
Coordinator, KSUMC-Wide CPG Steering Committee
Coordinator, Research & Development, Quality Management Dept.
9/9/2015 1
6th Residents Professional Development Course
College of Medicine, King Saud University
3. Learning objectives
• CPG Definitions & concepts
• How to scout for EBCPGs?
• How to appraise CPGs (standards)?
• Develop or adapt CPGs?
• CPG implementation?
• KSUMC CPG program
• How to access and use KSUMC CPGs ?
• What is your role as a physician?
9/9/2015 3
4. Evidence-Based Medicine (EBM)
Movement: Not new!
• 865–925 Al-Razi (Rhazes)
1st need for experiments, comparisons in clinical studies
• 981–1037 Ibn Sina (Avicenna)
test effect of drugs on humans not animals only
• 1987 David M. Eddy, MD, PhD
‘EB’ in EBCPGs, policies in workshops, manual
• 1992 Gordon Guyatt, MD
‘EBM’ term in JAMA
• 1996 David Sackett, MD
‘EBM’ definition in BMJ
4
9/9/2015
5. The Georg Ebers Papyrus.
Found in Egypt in the 1870s,
the Ebers Papyrus contains
prescriptions written in
hieroglyphics for
more than 700 remedies,
including this one for an acute
asthma attack.
From: University of Leipzig
9/9/2015 5
7. Definition: (old)
“Systematically developed statements to assist
practitioner and patient decisions about appropriate
health care for specific clinical circumstances”
(IOM 1990)
Increasing international interest in the development
& implementation of CPGs!
Clinical Practice Guidelines (CPGs)
79/9/2015
8. CPGs Definition (New)
“Statements that include Recommendations
intended to optimize patient care that are
informed by a Systematic Review of evidence
and an assessment of the benefits and harms
of alternative care options”
Committee on Standards for
Developing Trustworthy
CPGs (IOM-AHRQ 2011)
9/9/2015 8
10. Rationale for CPGs
• Worldwide concerns about:-
▫ Unexplained variation/ variability in clinical practice
▫ Rising healthcare costs
▫ Exponential growth of health information
• Aim of CPGs:-
To facilitate more consistent, effective and efficient practice
and improve health outcomes for patients
9/9/2015 10
17. Adaptation of CPGs
Is the systematic approach to the endorsement
and/or modification of a guideline(s) produced in
one cultural and organizational setting for
application in a different context. Adaptation may
be used as an alternative to de novo guideline
development, e.g., for customizing (an) existing
guideline(s) to suit the local context.
9/9/2015 17
19. Types of CPGs
The Role of CPGs in Health Care Reform (Rosoff AJ 1994)
CPGs are basically of two types:-
1. Quality-enhancing CPGs are primarily intended to
improve medical outcomes, often by increasing the
amount of care given.
2. Cost-reducing CPGs are oriented toward cutting costs,
generally, by limiting the amount of care given.
http://www.upenn.edu/ldi/issuebrief1_2.html
9/9/2015 19
20. Types of CPGs (cont’d)
1.Evidence-Based CPGs (evidence-
based methodology)
2.Consensus/ expert-based CPGs
9/9/2015 20
Which type do you think is better?
27. Organization Name
Country
URL Producer Finder FREE PAID
Guidelines International Network
(G-I-N)
Int’l http://www.g-i-n.net F √ √
World Health Organization (WHO) Int’l http://www.who.int/topics P √
National Institute for Health
& Clinical Excellence (NICE)
UK
http://www.nice.org.uk/page.aspx?o=ourguidanc
e
P √ √
Scottish Intercollegiate Guidelines Network (SIGN) Scotland http://www.sign.ac.uk/guidelines/index.html P √
New Zealand Guideline Group (NZGG) NZ http://www.nzgg.org.nz P √
Registered Nurses Association of Ontario (RNAO) Canada http://www.rnao.org P √
National Guidelines Clearinghouse (NGC) USA http://www.guidelines.gov F √
US National Library of Medicine, National
Institutes of Health (PubMed)
USA
http://www.ncbi.nlm.nih.gov/pubmed
OR http://www.pubmed.gov
F
√
(Abstra
cts)
√
(Full
Text
)
Institute for Clinical Systems Improvement (ICSI) USA http://www.icsi.org/knowledge/ P √
9/9/2015 27
45. Shaikh Bahamdan’s Research Chair for Evidence-Based Health Care
& Knowledge Translation
Member of G-I-N since Oct. 2009
Free access to International CPG Library of G-I-N
9/9/2015 45
63. 7. Systematic methods for E search
8. Selection Criteria of E
9. Strengths & Limitations of E
10. Methods of Rs formulation
11. Benefits , side effect and risks in Rs
12. Evidence Links (Gs of Rs – LoE)
13. External Review
14. Update Procedure
DOMAIN 3. RIGOUR OF DEVELOPMENT
9/9/2015 63
64. DOMAIN 4. CLARITY OF PRESENTATION
15. Rs are specific
16. Options for management
17. Recommendation identifiable
9/9/2015 64
67. CPG Implementation
“The concrete activities and interventions
undertaken to turn policies into desired
results“
Guidelines for clinical practice: from development to use. IOM, 1992
CPGs Practice
9/9/2015 67
68. Implementation research
is the scientific study of methods to promote the
systematic uptake of proven clinical treatments,
practices, organizational, and management interventions
into routine practice, and hence to improve health.
In this context, it includes the study of influences on
patient, healthcare professional, and organizational
behavior in either healthcare or population settings.
http://www.nlm.nih.gov/hsrinfo/implementation_science.html
9/9/2015 68
69. Implementation science
It is the study of methods to promote the
integration of research findings and evidence into
healthcare policy and practice.
It seeks to understand the behavior of healthcare professionals and other
stakeholders as a key variable in the sustainable uptake, adoption, and
implementation of evidence-based interventions.
As a newly emerging field, the definition of implementation science and the type of
research it encompasses may vary according [to] setting and sponsor. However, the
intent of implementation science and related research is to investigate and address
major bottlenecks (e.g. social, behavioral, economic, management) that impede
effective implementation, test new approaches to improve health programming, as
well as determine a causal relationship between the intervention and its impact.
http://www.nlm.nih.gov/hsrinfo/implementation_science.html
9/9/2015 69
70. Dissemination
Is the purposive distribution of information and
intervention materials to a specific public
health or clinical practice audience.
The intent is to spread information and the associated evidence-based
interventions. Research on dissemination addresses how information
about health promotion and care interventions is created, packaged,
transmitted, and interpreted among a variety of important stakeholder
groups.
http://www.nlm.nih.gov/hsrinfo/implementation_science.html
9/9/2015 70
71. CPG Implementability
Set of characteristics that PREDICT the relative
ease of implementation of CPG
recommendations.
Implementability is an abstract concept related to several factors, including
intrinsic factors that are specific to the CPG itself and under control of the
CPG development group and extrinsic factors that are often specific to the
intended healthcare settings and context of implementation.
Implementability…….BEFORE implementation
9/9/2015 71
72. CPG implementation Strategies (SIGN)
Dissemination Process (print/ e-/website).
Local Clinical Champions.
Awareness raising/ training activities.
Regular M & E (Auditing) (The ‘living’ CPG concept!).
Networking and linking with existing projects (e.g. Dept.
Clinical Rounds, CPD/CME activities, Accreditation, etc..).
Patients as champions for change.
729/9/2015
73. CPG implementation Tools
available at the point of care (* MR)
Examples
1.Clinical Algorithm
2.Integrated Care/ Clinical Pathways
3.Protocol and/ or Policy & Procedure
4.Chart Documentation/ forms (e.g. Physician Order Sets: eSIHI
CPOE PowerPlans)
5.Quick Reference Guides/ Physician Guides & Pocket
Guide/Reference Cards (at-a-glance summary of key
recommendations 5 or 1-2 pages).
739/9/2015
77. Barriers (Physician adherence to CPGs)*
I – KNOWLEDGE:-
• Lack of familiarity and/or Awareness
II – ATTITUDES:-
• Lack of agreement with specific CPGs
• Lack of agreement with CPGs in general
• Lack of outcome expectancy
• Lack of self-efficacy
• Lack of motivation/ inertia of previous practice
9/9/2015 77
78. Barriers (cont’d)
III – BEHAVIOR:-
• External factors (e.g. patient factors, care
system factors)
• Internal factors (CPG factors)
• Environmental factors
9/9/2015 78
*Enhancing the Use of Clinical Guidelines: A Social Norms Perspective
The McDonnell Norms Group 2006
79. Individual
Positive attitude
Learning through small
group interaction
Environmental
• Professional
association/society support
• Inter-organizational
collaboration networks
Facilitators
Organizational
• Leadership support
• Champions
• Team work
collaboration
9/9/2015 79
81. Clinical Practice Guidelines (CPGs) Program of King Saud
University Medical City
KSUMC CPG Program Partners:-
KSUMC-Wide CPGs Steering Committee;
Clinical Departments (20 CPGs Depart.
Committees);
Research Chair for Evidence-Based Health Care
and Knowledge Translation;
Quality Management Department; DQTs
Top Management & Leadership of KSU College
of Medicine and KSU Medical City
IMPLEMENT
QIP
ADAPT
Methods
9/9/2015 81
82. Guidelines International Network (G-I-N)
www.g-i-n.net
EBHC-KT Chair, King Saud University: Org. Member
since 2009
(1st Member from Gulf & 3rd Member from MENA
Countries)
Founded in Nov.
2002
9/9/2015 82
83. 23 KSUMC CPGs Subcommittees
1. Department of Pediatrics (7)
2. Department of Critical Care (
3. Department of Psychiatry
4. Primary Care/ Family Medicine Clinics
5. Department of Pharmacy
6. Department of Emergency Medicine
7. Department of Medicine
8. Department of Orthopedic Surgery
9. Department of Otorhinolaryngology
10. Department of Ophthalmology
11. Department of Cardiac Sciences/ KFCC
12. Department of Surgery
13. Department of Obstetrics & Gynecology
14. Department of Dermatology
15. Department of Anesthesiology
16. Department of Laboratory Medicine &
Pathology
17. Department of Nursing
18. Department of Radiology
19. Health Education Center
20. Department of Rehabilitation Medicine
21. Department of Infection Control
22. Department of Occupational Health & Safety
23. Department of Clinical Nutrition
839/9/2015
84. Health/ Clinical/ Key Questions
Patient (& disease characteristics)
Intervention(s)
Professionals (Target users)
Outcomes (purpose of the CPGs)
Healthcare settings (& context)
9/9/2015 84
CPG Scope: PIPOH Model
108. Pediatrics (7)
Pediatrics
(PED)
Pulmonology
1. Management of Acute Asthma exacerbations (DEM) (2nd Edition)
2. Management of Acute viral Bronchiolitis (DEM) (2nd Edition)
Endocrinology 3. Management of Diabetic Ketoacidosis in children (DEM) (2nd Edition)
Infectious Diseases
4. Management of Fever without a source in infants 60 days or less (DEM)
(1st Edition)
Neonatology 5. Management of Neonatal Hyperbilirubunemia (Jaundice) (1st Edition)
PICU
6. Management of Severe Sepsis and Septic Shock in infants and children
(DEM) (1st Edition)
Neurology 7. Management of Status Epilepticus in infants and children (1st Edition)
9/9/2015 108
109. Critical Care (ICU) (2)
Critical
Care (ICU)
MICU
1. Management of Severe Sepsis and Septic Shock
(Adult) (DEM) (1st Edition)
2. Venous Thromboembolism Prophylaxis (1st Edition)
9/9/2015 109
110. Medicine (6)
Medicine
(MED)
Pulmonology 1. Management of Asthma in Adults (DEM) (1st Edition)
Endocrinology
2. Management of Diabetic Ketoacidosis in Adults more than 12
years of age (DEM) (1st Edition)
Rheumatology 3. Management of Gout (acute/chronic) (DEM) (1st Edition)
Clinical Teaching
Unit
4. Management of Hypertensive Emergencies/Urgencies (DEM) (1st
Edition)
Hematology-
Oncology
5. Management of Lung Cancer (1st Edition)
6. Antiemetics for Chemotherapy induced Nausea & Vomiting (1st
Edition)
9/9/2015 110
115. Obstetrics & Gynecology (2)
Obstetrics
&
Gynecolog
y (OBGYN)
Maternal-Fetal
Medicine
1. Antenatal corticosteroids for fetal
maturation (PCC) (1st Edition)
IVF &
Reproductive
Techno.
2. Number of Embryos to transfer in IVF
Treatment (1st Edition)
9/9/2015 115